ITGAM and neoplasm: The percentages and numbers of CD11b+Ly‐6ChighLy‐6Glow Mo‐MDSCs and CD11b+Ly‐6CintLy‐6Ghigh PMN‐MDSCs were markedly increased in the spleens of tumor‐bearing mice, and oxaliplatin reduced total myeloid cells and both subsets of MDSCs, especially Mo‐MDSCs (Figure 1D‐F).